[PDF] Top 20 Anlisis sobre la homeopata como ciencia o pseudociencia
Has 10000 "Anlisis sobre la homeopata como ciencia o pseudociencia" found on our website. Below are the top 20 most common "Anlisis sobre la homeopata como ciencia o pseudociencia".
Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters
... Triple-negative Breast Cancers (TNBC) are a poor prog- nostic group of breast cancers and accounts for 20% of human breast cancers (Swain, 2008; Nakai et ...Estrogen Receptor ... See full document
6
Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo adjuvant chemotherapy in patients with triple negative breast cancer
... response (pCR) rate in TNBC patients than non-TNBC patients [20-23]. Our data indicated that pCR rate was significantly higher in TNBCs compared with non- TNBCs (P=0.012). Patients with non-TNBCs who achieved pCR were ... See full document
15
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor positive/human epidermal growth factor receptor type 2 negative breast cancer cases with early, late, and no recurrence
... positive/HER2-negative breast cancers were ...as triple-negative, HER2-positive, high histological grade, high Ki-67 expres- sion, and advanced TNM stage [13, 17, 18, 27, 28, 34, ...important ... See full document
13
Molecular biology of breast cancer metastasis Inflammatory breast cancer: clinical syndrome and molecular determinants
... This is certainly the case with colorectal carcinoma, in which over 70% of cases have a mutation in p53 [28]. Studies have indicated that on average 30% of breast cancers contain mutations in one of the p53 ... See full document
9
Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer
... of cancer cells and may also have the potential to be thera- peutic targets ...to negative tu- mors (C17orf56, CSNK1D, DUS1L, FN3KRP , HGS, SIRT7, SCL25A10, ...to cancer development and ...and ... See full document
11
<p>Epidermal growth factor receptor (<em>EGFR</em>) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohort</p>
... hormone receptor-positive, or HER2-positive breast cancer bene fi t from anti-hormonal or HER2-targeted ...endothelial growth factor and proliferation signal- ing focusing on agents for ... See full document
6
Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)
... Eribulin, a non-taxane microtubule inhibitor, is an effective therapeutic agent for MBC patients [9]. It induced neuropathy in about 30% of patients, which was significantly lower than the rate of paclitaxel-induced ... See full document
207
Prognostic value of <em>EGFR</em> and <em>KRAS</em> in resected non-small cell lung cancer: a systematic review and meta-analysis
... KRAS mutations are a negative factor of DFS and OS in patients with postoperative NSCLC. The meta-analysis revealed that the resected NSCLC patients with KRAS muta- tions exhibited reduced DFS and OS. This ... See full document
48
Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer
... the prognostic value of BCDIN3D in breast cancer ...BCDIN3D negative group supports previous biological function study results from other ...this association was found to be most ... See full document
20
<em>EGFR</em>, <em>KRAS</em>, <em>BRAF</em>, <em>PTEN</em>, and <em>PIK3CA </em>mutation in plasma of small cell lung cancer patients
... lung cancer (SCLC) is an aggressive and deadly neuroendocrine tumor derived from bronchial epithelial ...in epidermal growth factor receptor (EGFR), Kirsten rat sarcoma viral oncogene ... See full document
12
Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
... independent prognostic variable. Further, in that study, the PS and IS parameters were not analyzed separately, and the TS parameter was achieved by multiplying the PS and IS, whereas, in our study, the TS ... See full document
12
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
... In this study, we report the presence of EGFR muta- tions, notably exon 19 deletions and exon 21 missense (L858R) mutations, in 11.8% of triple negative breast cancers evaluated. All samples showed ... See full document
5
Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer
... scription factor mediates this event. Nuclear factor-κB (NF-κB) is a well-known transcription factor that associ- ates with ER-negative breast cancers, exists mainly in human BLBC ... See full document
90
Comparative Insilico Docking Analysis of Curcumin and Resveratrol on Breast Cancer Proteins and their Synergistic Effect on MCF-7 Cell Line
... Cancer is a disease with abnormal cell growth and uncontrolled multipli- cation of the cells within the body. Cancer therapy is currently modelled by surgery, radiotherapy and chemotherapy. Most ... See full document
64
Impact of tumor biomarkers and patient’s age on the “disease stage” in women with breast cancer in Erbil city
... of breast cancer among the studied women was 48 ...of breast cancer cases were diagnosed in young women aged less than 40 ...advanced breast cancer (disease stages II and III); ... See full document
13
A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas
... in breast carcinomas is not uncommon ...positive breast tumors are often multifocal (28% and 48%, re- spectively) ...bilateral breast carcinomas and molecular subtypes and found that basal-like ... See full document
38
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
... consistently expressed in myoepithelial cells of the breast [40]. We [26,41,42] and others [30,31,43-45] have demonstrated that the vast majority of MBCs consistently express basal/ myoepithelial markers. ... See full document
22
Does consuming isoflavones reduce or increase breast cancer risk?
... ERβ. In theory, the effect of isoflavones would vary from being antiestrogenic to weakly estrogenic depending on whether the women have high or low endogenous estrogen levels (which are generally 50 to 400 pg/ml in ... See full document
13
Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway
... expression features of proliferating ZR-75-1 ...Furthermore, growth of BCAR1 and BCAR3 transfectants (which are fully responsive to oestrogen; Table 3 and Additional file 1) was not stimulated by anti- ... See full document
19
Future Oncology: Technology, Products, Market and Service Opportunities
... the cancer and related fields such as the International Congress on Anti-Cancer Chemotherapy (ICACC); International Conference on Monoclonal Antibody Immunoconjugates for Cancer; Annual Meeting of ... See full document
23
Related subjects